MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA

The results of the microbiological diagnosis of infective inflammatory complications in patients with iatrogenic esophageotracheal fistula and the tactics of their antibacterial prophylaxis and therapy within a 9-year observation period (2003-2011) were analysed. The main organisms colonizing the tr...

Full description

Saved in:
Bibliographic Details
Main Authors: N. S. Bogomolova, V. D. Parshin, G. A. Vishnevskaya, L. N. Bolshakov, S. M. Kuznetsova
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/427
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849692704635617280
author N. S. Bogomolova
V. D. Parshin
G. A. Vishnevskaya
L. N. Bolshakov
S. M. Kuznetsova
author_facet N. S. Bogomolova
V. D. Parshin
G. A. Vishnevskaya
L. N. Bolshakov
S. M. Kuznetsova
author_sort N. S. Bogomolova
collection DOAJ
description The results of the microbiological diagnosis of infective inflammatory complications in patients with iatrogenic esophageotracheal fistula and the tactics of their antibacterial prophylaxis and therapy within a 9-year observation period (2003-2011) were analysed. The main organisms colonizing the tracheobronchial tree in the patients were S.epidermidis, S.aureus, enteric bacteria, P.aeruginosa and Candida. An increase of the S.epidermidis resistance to rifampicin, moxifloxacin and especially ciprofloxacin was observed. The resistance of S.aureus did not significantly change. Within the observation period, high susceptibility of all the Staphylococcus isolates to vancomycin and linezolid remained stable. Among the nonfermenting gramnegative bacteria, the P.aeruginosa isolates were the most frequent and characterized by a lower portion of the isolates with preserved susceptibility to the agents (except polymyxin B) known earlier as antipyocyanic antibiotics, i.e. to imipenem and cefepim. Since the proportion of P.aeruginosa in the etiology of pyoinflammatory processes in the region of esophageotracheal fistula ranged within 9.3 to 17.5%, the fact should be considered in the antibiotic therapy. There was observed an increase in the frequency of infectious complications due to other nonfermenting gramnegative bacteria (acinetobacters) and first of all A.baumannii. Various Candida isolates were characterized by dependence of the susceptibility on the selective pressure of nonrational therapy, as well as their species (the presence of such species as C.Krusei and C.glabrata with natural resistance), that required not only the species identification but also determination of the Candida isolates resistance in every particular case.
format Article
id doaj-art-7a57858da3a4488d93e5e45a2ccfb204
institution DOAJ
issn 0235-2990
language Russian
publishDate 2020-05-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-7a57858da3a4488d93e5e45a2ccfb2042025-08-20T03:20:38ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01573-41824426MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULAN. S. Bogomolova0V. D. Parshin1G. A. Vishnevskaya2L. N. Bolshakov3S. M. Kuznetsova4B. I. Petrovsky Russian Scientific Centre of SurgeryB. I. Petrovsky Russian Scientific Centre of SurgeryB. I. Petrovsky Russian Scientific Centre of SurgeryB. I. Petrovsky Russian Scientific Centre of SurgeryB. I. Petrovsky Russian Scientific Centre of SurgeryThe results of the microbiological diagnosis of infective inflammatory complications in patients with iatrogenic esophageotracheal fistula and the tactics of their antibacterial prophylaxis and therapy within a 9-year observation period (2003-2011) were analysed. The main organisms colonizing the tracheobronchial tree in the patients were S.epidermidis, S.aureus, enteric bacteria, P.aeruginosa and Candida. An increase of the S.epidermidis resistance to rifampicin, moxifloxacin and especially ciprofloxacin was observed. The resistance of S.aureus did not significantly change. Within the observation period, high susceptibility of all the Staphylococcus isolates to vancomycin and linezolid remained stable. Among the nonfermenting gramnegative bacteria, the P.aeruginosa isolates were the most frequent and characterized by a lower portion of the isolates with preserved susceptibility to the agents (except polymyxin B) known earlier as antipyocyanic antibiotics, i.e. to imipenem and cefepim. Since the proportion of P.aeruginosa in the etiology of pyoinflammatory processes in the region of esophageotracheal fistula ranged within 9.3 to 17.5%, the fact should be considered in the antibiotic therapy. There was observed an increase in the frequency of infectious complications due to other nonfermenting gramnegative bacteria (acinetobacters) and first of all A.baumannii. Various Candida isolates were characterized by dependence of the susceptibility on the selective pressure of nonrational therapy, as well as their species (the presence of such species as C.Krusei and C.glabrata with natural resistance), that required not only the species identification but also determination of the Candida isolates resistance in every particular case.https://www.antibiotics-chemotherapy.ru/jour/article/view/427esophageotracheal fistulamicrobiological monitoring
spellingShingle N. S. Bogomolova
V. D. Parshin
G. A. Vishnevskaya
L. N. Bolshakov
S. M. Kuznetsova
MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA
Антибиотики и Химиотерапия
esophageotracheal fistula
microbiological monitoring
title MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA
title_full MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA
title_fullStr MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA
title_full_unstemmed MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA
title_short MICROBIOLOGICAL MONITORING IN THERAPY OF PATIENTS WITH IATROGENIC ESOPHAGEOTRACHEAL FISTULA
title_sort microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula
topic esophageotracheal fistula
microbiological monitoring
url https://www.antibiotics-chemotherapy.ru/jour/article/view/427
work_keys_str_mv AT nsbogomolova microbiologicalmonitoringintherapyofpatientswithiatrogenicesophageotrachealfistula
AT vdparshin microbiologicalmonitoringintherapyofpatientswithiatrogenicesophageotrachealfistula
AT gavishnevskaya microbiologicalmonitoringintherapyofpatientswithiatrogenicesophageotrachealfistula
AT lnbolshakov microbiologicalmonitoringintherapyofpatientswithiatrogenicesophageotrachealfistula
AT smkuznetsova microbiologicalmonitoringintherapyofpatientswithiatrogenicesophageotrachealfistula